-
Saquinavir: HIV Protease Inhibitor Research Guide
2026-08-15
Saquinavir is an HIV protease inhibitor that blocks proteolytic maturation of HIV viral particles. This guide connects its molecular identity and reagent handling requirements with antiretroviral drug research and biomimetic permeability-modeling limits.
-
DRB Workflows for Transcriptional Elongation
2026-08-14
DRB provides a rapid, reversible way to probe transcriptional elongation alongside stem-cell fate transitions, signaling, and antiviral phenotypes. This workflow connects CDK-dependent RNA regulation with the YTHDF1 phase-separation model while emphasizing dose, timing, and interpretation controls.
-
Nose-to-Brain mRNA-LNP Delivery for CNS Therapy
2026-08-14
This ACS Nano study develops an intranasal, brain-targeting lipid nanoparticle platform that uses surface-charge screening to improve mRNA delivery through olfactory and trigeminal pathways. In a repetitive mild traumatic brain injury model, co-delivery of BDNF and IL-10 mRNAs reduced neuroinflammation and neuronal loss while improving cognition, illustrating a noninvasive strategy for CNS gene therapy.
-
Esflurbiprofen and SERT–nNOS: Fast Antidepressant Action
2026-08-13
The reference study identifies esflurbiprofen as a fast-onset antidepressant candidate by screening for compounds that disrupt the SERT–nNOS complex in the dorsal raphe nucleus. Its combined interaction assay, stress-model, behavioral, imaging, and mechanistic data support a circuit-level strategy for relieving serotonergic autoreceptor feedback, while also defining important limits for translation beyond mice.
-
Bergenin Targets γδT17 Cells in Psoriasis
2026-08-13
A 2026 Phytomedicine study identifies a previously underappreciated PPARγ–PROX1 pathway through which bergenin suppresses pathogenic γδT17 cells and IL-17A production in psoriasis models. Its combination of immune-cell profiling, metabolic analysis, ubiquitination studies, and chromatin assays links PPARγ activation to CPT1-dependent fatty acid oxidation and inflammatory transcription.
-
NVP-BGJ398 Phosphate: FGFR Research Guide
2026-08-12
NVP-BGJ398 phosphate, also called BGJ-398 phosphate, is a potent pan-FGFR1–3 inhibitor for biomarker-defined cancer and skeletal-disease research. Product data and a peer-reviewed mouse study support its use for interrogating FGFR signaling, while potency, model, formulation, and translational limits require careful interpretation.
-
Bazedoxifene: SERM Workflows for Osteoporosis Research
2026-08-12
Build reproducible estrogen-receptor and bone-model assays with Bazedoxifene, a tissue-selective SERM suited to postmenopausal osteoporosis research. A reference-led extension also shows how the same compound can support carefully controlled antimalarial repurposing studies through hemozoin-focused readouts.
-
Cy5 maleimide for Condensate Protein Labeling
2026-08-11
Cy5 maleimide enables site-selective cysteine labeling for protein tracking, imaging, and condensate partitioning assays. This practical guide combines solvent handling, conjugation controls, quantitative fluorescence readouts, and lessons from recent α-synuclein phase-separation research.
-
Cy5 Goat Anti-Mouse IgG (H+L): Mechanistic Imaging
2026-08-11
Discover how the Cy5 Goat Anti-Mouse IgG (H+L) Antibody can translate exosome and Wnt/β-catenin biology into interpretable fluorescence assays. This guide connects the reagent’s molecular design with osteogenesis research, controls, storage, and evidence-based assay decisions.
-
BMS-777607 Workflows for MET and Platelet Research
2026-08-10
BMS-777607 provides a selective way to interrogate MET-family signaling in cancer metastasis models while offering a hypothesis-driven tool for iPSC-derived megakaryocyte studies. This guide connects target-engagement assays, metastatic phenotyping, and the latest platelet-differentiation workflow without overstating the current evidence.
-
ARCA Cy5 EGFP mRNA (5-moUTP) Workflow
2026-08-09
Build a dual-readout workflow that separates mRNA delivery and localization from productive translation in mammalian cells. ARCA capping, 5-methoxyuridine modification, Cy5 tracking, and EGFP expression provide a practical benchmark for optimizing nanoparticles, transfection conditions, and intracellular trafficking.
-
ARCA Cy5 EGFP mRNA (5-moUTP): Assay Design
2026-08-08
ARCA Cy5 EGFP mRNA (5-moUTP) enables a two-axis view of mRNA uptake and protein expression. This guide connects fluorescent readouts to delivery-system design, with practical strategies for interpreting localization, translation, and immune-cell targeting.
-
Coumestrol in RA-FLS Ferroptosis Research
2026-08-07
Coumestrol connects estrogen-receptor pharmacology with a practical rheumatoid arthritis fibroblast-like synoviocyte workflow centered on ferroptosis, mitochondrial stress, and PMAIP1 stability. This guide covers treatment setup, orthogonal readouts, nuclear receptor comparisons, and troubleshooting for reproducible research use.
-
ARCA Cy5 EGFP mRNA (5-moUTP): Tracking mRNA Delivery & Effic
2026-08-07
ARCA Cy5 EGFP mRNA (5-moUTP) empowers direct, quantitative analysis of mRNA delivery, localization, and translation efficiency in mammalian cells. Its dual-labeling and 5-methoxyuridine modification streamline troubleshooting and boost reproducibility for advanced mRNA delivery system research.
-
ARCA Cy5 EGFP mRNA (5-moUTP): Precision mRNA Localization To
2026-08-06
ARCA Cy5 EGFP mRNA (5-moUTP) is a benchmark 5-methoxyuridine modified mRNA reagent enabling direct, dual-mode visualization of mRNA delivery and translation in mammalian cells. It incorporates ARCA capping and Cy5 labeling, ensuring high translational efficiency and immune evasion in quantitative mRNA localization and transfection assays.